J.H. Whitney Equity Partners V Sells 1,560,700 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the business’s stock in a transaction on Monday, May 19th. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00. Following the completion of the transaction, the insider now directly owns 29,640,756 shares in the company, valued at approximately $158,874,452.16. This represents a 5.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Monday, May 12th, J.H. Whitney Equity Partners V sold 47,039 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.72, for a total value of $269,063.08.
• On Tuesday, April 1st, J.H. Whitney Equity Partners V sold 5,580 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total value of $31,415.40.
• On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total value of $1,508.84.
• On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.51, for a total value of $339,217.64.

Aveanna Healthcare Price Performance

Shares of NASDAQ AVAH opened at $5.35 on Friday. Aveanna Healthcare Holdings Inc. has a one year low of $2.32 and a one year high of $6.19. The business’s fifty day moving average price is $5.10 and its 200-day moving average price is $4.95. The stock has a market capitalization of $1.04 billion, a PE ratio of -15.73 and a beta of 2.01.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Truist Financial cut their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, April 11th. UBS Group upped their price target on Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a research report on Friday, May 9th.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in AVAH. JPMorgan Chase & Co. lifted its position in shares of Aveanna Healthcare by 266.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 85,714 shares of the company’s stock valued at $446,000 after buying an additional 62,319 shares during the last quarter. SG Americas Securities LLC lifted its holdings in Aveanna Healthcare by 26.0% during the 4th quarter. SG Americas Securities LLC now owns 24,366 shares of the company’s stock worth $111,000 after purchasing an additional 5,031 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in Aveanna Healthcare by 15.7% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 25,171 shares of the company’s stock worth $115,000 after purchasing an additional 3,407 shares in the last quarter. Legato Capital Management LLC purchased a new stake in Aveanna Healthcare during the 4th quarter worth about $83,000. Finally, Rhumbline Advisers lifted its holdings in Aveanna Healthcare by 11.1% during the 4th quarter. Rhumbline Advisers now owns 72,663 shares of the company’s stock worth $332,000 after purchasing an additional 7,257 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.